BALYASNY ASSET MANAGEMENT L.P. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 209 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$2,206,000
+155.9%
111,397
+154.5%
0.01%
+100.0%
Q3 2021$862,000
+32.6%
43,778
-18.5%
0.00%0.0%
Q4 2019$650,000
+94.6%
53,736
+127.3%
0.00%
+100.0%
Q3 2019$334,000
-59.0%
23,645
-67.6%
0.00%
-60.0%
Q2 2019$814,000
+48.8%
73,025
+119.5%
0.01%
+150.0%
Q1 2018$547,000
+543.5%
33,263
+184.2%
0.00%
Q4 2016$85,000
+1.2%
11,704
-9.3%
0.00%
Q3 2016$84,000
-54.1%
12,902
-67.0%
0.00%
-100.0%
Q1 2016$183,00039,1400.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders